Cargando…
Case Report: Heterozygous Germline Variant in EIF6 Additional to Biallelic SBDS Pathogenic Variants in a Patient With Ribosomopathy Shwachman–Diamond Syndrome
Background: Shwachman–Diamond syndrome (SDS) is a rare autosomal recessive ribosomopathy mainly characterized by exocrine pancreatic insufficiency, skeletal alterations, neutropenia, and a relevant risk of hematological transformation. At least 90% of SDS patients have pathogenic variants in SBDS, t...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411639/ https://www.ncbi.nlm.nih.gov/pubmed/36035165 http://dx.doi.org/10.3389/fgene.2022.896749 |
_version_ | 1784775313357537280 |
---|---|
author | Taha, Ibrahim Foroni, Selena Valli, Roberto Frattini, Annalisa Roccia, Pamela Porta, Giovanni Zecca, Marco Bergami, Elena Cipolli, Marco Pasquali, Francesco Danesino, Cesare Scotti, Claudia Minelli, Antonella |
author_facet | Taha, Ibrahim Foroni, Selena Valli, Roberto Frattini, Annalisa Roccia, Pamela Porta, Giovanni Zecca, Marco Bergami, Elena Cipolli, Marco Pasquali, Francesco Danesino, Cesare Scotti, Claudia Minelli, Antonella |
author_sort | Taha, Ibrahim |
collection | PubMed |
description | Background: Shwachman–Diamond syndrome (SDS) is a rare autosomal recessive ribosomopathy mainly characterized by exocrine pancreatic insufficiency, skeletal alterations, neutropenia, and a relevant risk of hematological transformation. At least 90% of SDS patients have pathogenic variants in SBDS, the first gene associated with the disease with very low allelic heterogeneity; three variants, derived from events of genetic conversion between SBDS and its pseudogene, SBDSP1, provided the alleles observed in about 62% of SDS patients. Methods: We performed a reanalysis of the available WES files of a group of SDS patients with biallelic SBDS pathogenic variants, studying the results by next bioinformatic and protein structural analysis. Parallelly, careful clinical attention was given to the patient focused in this study. Results: We found and confirmed in one SDS patient a germline heterozygous missense variant (c.100T>C; p.Phe34Leu) in the EIF6 gene. This variant, inherited from his mother, has a very low frequency, and it is predicted as pathogenic, according to several in silico prediction tools. The protein structural analysis also envisages the variant could reduce the binding to the nascent 60S ribosomal. Conclusion: This study focused on the hypothesis that the EIF6 germline variant mimics the effect of somatic deletions of chromosome 20, always including the locus of this gene, and similarly may rescue the ribosomal stress and ribosomal dysfunction due to SBDS mutations. It is likely that this rescue may contribute to the stable and not severe hematological status of the proband, but a definite answer on the role of this EIF6 variant can be obtained only by adding a functional layer of evidence. In the future, these results are likely to be useful for selected cases in personalized medicine and therapy. |
format | Online Article Text |
id | pubmed-9411639 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94116392022-08-27 Case Report: Heterozygous Germline Variant in EIF6 Additional to Biallelic SBDS Pathogenic Variants in a Patient With Ribosomopathy Shwachman–Diamond Syndrome Taha, Ibrahim Foroni, Selena Valli, Roberto Frattini, Annalisa Roccia, Pamela Porta, Giovanni Zecca, Marco Bergami, Elena Cipolli, Marco Pasquali, Francesco Danesino, Cesare Scotti, Claudia Minelli, Antonella Front Genet Genetics Background: Shwachman–Diamond syndrome (SDS) is a rare autosomal recessive ribosomopathy mainly characterized by exocrine pancreatic insufficiency, skeletal alterations, neutropenia, and a relevant risk of hematological transformation. At least 90% of SDS patients have pathogenic variants in SBDS, the first gene associated with the disease with very low allelic heterogeneity; three variants, derived from events of genetic conversion between SBDS and its pseudogene, SBDSP1, provided the alleles observed in about 62% of SDS patients. Methods: We performed a reanalysis of the available WES files of a group of SDS patients with biallelic SBDS pathogenic variants, studying the results by next bioinformatic and protein structural analysis. Parallelly, careful clinical attention was given to the patient focused in this study. Results: We found and confirmed in one SDS patient a germline heterozygous missense variant (c.100T>C; p.Phe34Leu) in the EIF6 gene. This variant, inherited from his mother, has a very low frequency, and it is predicted as pathogenic, according to several in silico prediction tools. The protein structural analysis also envisages the variant could reduce the binding to the nascent 60S ribosomal. Conclusion: This study focused on the hypothesis that the EIF6 germline variant mimics the effect of somatic deletions of chromosome 20, always including the locus of this gene, and similarly may rescue the ribosomal stress and ribosomal dysfunction due to SBDS mutations. It is likely that this rescue may contribute to the stable and not severe hematological status of the proband, but a definite answer on the role of this EIF6 variant can be obtained only by adding a functional layer of evidence. In the future, these results are likely to be useful for selected cases in personalized medicine and therapy. Frontiers Media S.A. 2022-08-12 /pmc/articles/PMC9411639/ /pubmed/36035165 http://dx.doi.org/10.3389/fgene.2022.896749 Text en Copyright © 2022 Taha, Foroni, Valli, Frattini, Roccia, Porta, Zecca, Bergami, Cipolli, Pasquali, Danesino, Scotti and Minelli. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Genetics Taha, Ibrahim Foroni, Selena Valli, Roberto Frattini, Annalisa Roccia, Pamela Porta, Giovanni Zecca, Marco Bergami, Elena Cipolli, Marco Pasquali, Francesco Danesino, Cesare Scotti, Claudia Minelli, Antonella Case Report: Heterozygous Germline Variant in EIF6 Additional to Biallelic SBDS Pathogenic Variants in a Patient With Ribosomopathy Shwachman–Diamond Syndrome |
title | Case Report: Heterozygous Germline Variant in EIF6 Additional to Biallelic SBDS Pathogenic Variants in a Patient With Ribosomopathy Shwachman–Diamond Syndrome |
title_full | Case Report: Heterozygous Germline Variant in EIF6 Additional to Biallelic SBDS Pathogenic Variants in a Patient With Ribosomopathy Shwachman–Diamond Syndrome |
title_fullStr | Case Report: Heterozygous Germline Variant in EIF6 Additional to Biallelic SBDS Pathogenic Variants in a Patient With Ribosomopathy Shwachman–Diamond Syndrome |
title_full_unstemmed | Case Report: Heterozygous Germline Variant in EIF6 Additional to Biallelic SBDS Pathogenic Variants in a Patient With Ribosomopathy Shwachman–Diamond Syndrome |
title_short | Case Report: Heterozygous Germline Variant in EIF6 Additional to Biallelic SBDS Pathogenic Variants in a Patient With Ribosomopathy Shwachman–Diamond Syndrome |
title_sort | case report: heterozygous germline variant in eif6 additional to biallelic sbds pathogenic variants in a patient with ribosomopathy shwachman–diamond syndrome |
topic | Genetics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411639/ https://www.ncbi.nlm.nih.gov/pubmed/36035165 http://dx.doi.org/10.3389/fgene.2022.896749 |
work_keys_str_mv | AT tahaibrahim casereportheterozygousgermlinevariantineif6additionaltobiallelicsbdspathogenicvariantsinapatientwithribosomopathyshwachmandiamondsyndrome AT foroniselena casereportheterozygousgermlinevariantineif6additionaltobiallelicsbdspathogenicvariantsinapatientwithribosomopathyshwachmandiamondsyndrome AT valliroberto casereportheterozygousgermlinevariantineif6additionaltobiallelicsbdspathogenicvariantsinapatientwithribosomopathyshwachmandiamondsyndrome AT frattiniannalisa casereportheterozygousgermlinevariantineif6additionaltobiallelicsbdspathogenicvariantsinapatientwithribosomopathyshwachmandiamondsyndrome AT rocciapamela casereportheterozygousgermlinevariantineif6additionaltobiallelicsbdspathogenicvariantsinapatientwithribosomopathyshwachmandiamondsyndrome AT portagiovanni casereportheterozygousgermlinevariantineif6additionaltobiallelicsbdspathogenicvariantsinapatientwithribosomopathyshwachmandiamondsyndrome AT zeccamarco casereportheterozygousgermlinevariantineif6additionaltobiallelicsbdspathogenicvariantsinapatientwithribosomopathyshwachmandiamondsyndrome AT bergamielena casereportheterozygousgermlinevariantineif6additionaltobiallelicsbdspathogenicvariantsinapatientwithribosomopathyshwachmandiamondsyndrome AT cipollimarco casereportheterozygousgermlinevariantineif6additionaltobiallelicsbdspathogenicvariantsinapatientwithribosomopathyshwachmandiamondsyndrome AT pasqualifrancesco casereportheterozygousgermlinevariantineif6additionaltobiallelicsbdspathogenicvariantsinapatientwithribosomopathyshwachmandiamondsyndrome AT danesinocesare casereportheterozygousgermlinevariantineif6additionaltobiallelicsbdspathogenicvariantsinapatientwithribosomopathyshwachmandiamondsyndrome AT scotticlaudia casereportheterozygousgermlinevariantineif6additionaltobiallelicsbdspathogenicvariantsinapatientwithribosomopathyshwachmandiamondsyndrome AT minelliantonella casereportheterozygousgermlinevariantineif6additionaltobiallelicsbdspathogenicvariantsinapatientwithribosomopathyshwachmandiamondsyndrome |